ELMTElmet Group Co. (The)
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $0.35Beat
- vs $0.15 expected on Nov 9
- Price
- $20.50
- −2.43% today · $574M cap
Past and upcoming reports
1
| Nov 9, 2026 | Sep 30, 2026 | Time not given | $0.15 | Beat$0.35 |
After the report
Nov 9, 2026 report
ELMT reported a 133.3% EPS beat, but expansion execution and 2.0% operating margins remain decisive
Elmet Group reported $0.35 EPS for the quarter ended September 30, versus $0.15 estimated, while shares rose 8.26% to $20.98 on November 11. No formal forward guidance or post-earnings news was provided. the forward setup therefore depends on tungsten expansion milestones, demand, pricing, and margin conversion. The stock trades at 35.1x forward earnings versus a 26.4x sector average, leaving limited room for execution disappointment.
Reported against expected
Reported EPS was $0.35 for the quarter ended September 30, beating the $0.15 estimate by $0.20, or 133.3%.
Guidance
No formal guidance or guidance update was provided in the payload. forward expectations center on expansion execution rather than quantified targets.
How the stock reacted
Shares rose $1.60, or 8.26%, to $20.98 on November 11, with 975,428 shares traded. event-day and subsequent reaction percentages were unavailable.
What changed
Reported EPS reached $0.35 versus $0.15 expected, a $0.20 positive surprise after the September 30 quarter.
What the price now assumes
The 8.26% rise to $20.98 reflects support for expansion, despite 35.1x forward earnings versus the sector’s 26.4x.
What it means for the business
Upgrade bias is conditional: add only if expansion milestones improve margins above 2.0% without weakening industrial demand.
The next one to three months, as we saw it then
Better case35%
The EPS beat funds continued tungsten expansion, and execution begins converting 20.0% TTM revenue growth into improved profitability.
Base case40%
The beat supports the shares, but premium valuation and limited margin data keep ELMT range-bound until expansion outcomes become measurable.
Worse case25%
Weak industrial demand or pricing prevents thin-margin revenue growth from becoming durable earnings, exposing the premium multiple.
If you hold it
Hold unless operating margin falls below 2.0% or expansion execution shows no measurable progress within 90 days.
If you are watching
Add only after a documented expansion milestone and margin improvement above 2.0%. no trade if execution remains unquantified or industrial demand weakens.
Scenario odds are a judgement, not measured.